US · Healthcare · Diagnostics & Research
EPS came in at -0.71 against a street estimate of -0.86 — a beat of 17.4%.
Analysts rate Biodesix Inc a strong buy (7 buy, 0 hold, 0 sell out of 7) with an average price target of $39.00.
| Fund | Stake |
|---|---|
| AIGH Capital Management, LLC | 6.43% |
| Soleus Capital Management, L.P. | 5.55% |
| Telemark Asset Management, LLC | 4.64% |
| Aberdeen Group PLC | 3.68% |
| Vanguard Capital Management, LLC | 2.69% |
| Essex Investment Management Company, LLC | 2.29% |
| Opaleye Management Inc | 1.71% |
| Marshall Wace Asset Management Ltd | 1.10% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Biodesix Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.